Dr. Modjarrad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health
40 Convent Drive, Room 2508 MSC3017
Bethesda, MD 20892Phone+1 301-594-8555- Is this information wrong?
Education & Training
- National Institutes of Health Clinical CenterFellowship, Infectious Disease, 2012 - 2013
- Vanderbilt University Medical CenterFellowship, Infectious Disease, 2010 - 2012
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2008 - 2010
- Yale-New Haven Medical CenterInternship, Internal Medicine, 2006 - 2007
- University of Alabama School of MedicineClass of 2006
Certifications & Licensure
- WV State Medical License 2012 - 2025
- MD State Medical License 2016 - 2025
- VA State Medical License 2012 - 2016
- TN State Medical License 2010 - 2014
Publications & Presentations
PubMed
- Lassa virus in novel hosts: insights into the epidemiology of lassa virus infections in southern Nigeria.Anise Nkenjop Happi, Olusola Akinola Ogunsanya, Akeemat Opeyemi Ayinla, Ayotunde Elijah Sijuwola, Femi Mudasiru Saibu, Kazeem Akano, Cecilia Nwofoke, Obineche Tobias E...> ;Emerging Microbes & Infections. 2024 Dec 1
- Protective efficacy of a Zika purified inactivated virus vaccine candidate during pregnancy in marmosets.Kim, I., Gonzalez, O., Tighe, M., Lanthier, P., Clark, M., Travis, K., Low-Beer, T., Lanzer, K., Bernacki, D., Szaba, F., De La Barrera, R., Dussupt, V., Mendez-Rivera...> ;NPJ Vaccines. 2024 Feb 17
- 1 citationsZika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent mice.Kim, I., Tighe, M., Lanthier, P., Clark, M., De La Barrera, R., Dussupt, V., Mendez-Rivera, L., Krebs, S., Travis, K., Low-Beer, T., Cookenham, T., Lanzer, K., Bernack...> ;NPJ Vaccines. 2024 Feb 15
- Join now to see all
Press Mentions
- Development of Universal COVID Vaccine Emerges as New Challenge for Pharmaceutical IndustryApril 23rd, 2022
- Pan-Coronavirus Vaccines May Be Key to Fighting Future PandemicsMarch 8th, 2022
- U.S. Army Begins Human Trials of Pan-Coronavirus VaccineJanuary 31st, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: